Clindamycin Hydrochloride Capsules recalled over manufacturing violations
- Recall date
- April 18, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, ND…
- Recall number
- D-0391-2025
- FDA classification
- Class II
- Brand / firm
- Preferred Pharmaceuticals, Inc.
- Sold / distributed
- Nationwide in the US
Why it was recalled
cGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Get recall alerts
Free email alert whenever Preferred Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Preferred Pharmaceuticals, Inc.